Biomarker Discovery from Pancreatic Cancer Secretome Using a Differential Proteomic Approach

This publication has 99 references indexed in Scilit:

• The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer
  European Journal of Surgical Oncology, 2005
• Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but not vascular endothelial growth factor receptors
  Cancer, 2004
• Development of Human Protein Reference Database as an Initial Platform for Approaching Systems Biology in Humans
  Genome Research, 2003
• Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors
  Proceedings of the National Academy of Sciences, 2003
• Interrelating Different Types of Genomic Data, from Proteome to Secretome: 'Oming in on Function
  Genome Research, 2001
• Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo.
  Journal of Clinical Investigation, 1998
• Comparative Phenotypic Studies of Duct Epithelial Cell Lines Derived from Normal Human Pancreas and Pancreatic Carcinoma
  The American Journal of Pathology, 1998
• The ins and outs of the transmembrane 4 superfamily
  Immunology Today, 1994
• Integrins: Versatility, modulation, and signaling in cell adhesion
  Cell, 1992
• Heparan sulfate proteoglycan of human colon: Partial molecular cloning, cellular expression, and mapping of the gene (HSPG2) to the short arm of human chromosome 1
  Genomics, 1991